172 related articles for article (PubMed ID: 2908604)
21. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
[TBL] [Abstract][Full Text] [Related]
22. Clinical applications of antiandrogens.
Namer M
J Steroid Biochem; 1988 Oct; 31(4B):719-29. PubMed ID: 2462132
[TBL] [Abstract][Full Text] [Related]
23. The kinetics of antiandrogens in humans.
Tremblay D; Dupront A; Meyer BH; Pottier J
Prog Clin Biol Res; 1987; 243A():341-50. PubMed ID: 2958859
[No Abstract] [Full Text] [Related]
24. [Application of antiandrogens on prostatic diseases].
Takahashi S; Hasegawa F; Isurugi K
Nihon Rinsho; 1994 Mar; 52(3):809-14. PubMed ID: 7513031
[TBL] [Abstract][Full Text] [Related]
25. Effect of cyproterone acetate in comparison to flutamide on the ventral prostate of adult male castrated Copenhagen-Fisher rats and on Dunning R-3327 H tumors.
Donn F; Becker H; Klosterhalfen H; Klein H
Andrologia; 1989; 21(5):462-7. PubMed ID: 2530921
[TBL] [Abstract][Full Text] [Related]
26. Initiation of LHRH monotherapy for prostate cancer.
Milsted RA
Prog Clin Biol Res; 1989; 303():69-74. PubMed ID: 2528742
[No Abstract] [Full Text] [Related]
27. Treatment with antiandrogens induces an androgen-repressed gene in the rat ventral prostate.
Léger JG; Le Guellec R; Tenniswood MP
Prostate; 1988; 13(2):131-42. PubMed ID: 2459682
[TBL] [Abstract][Full Text] [Related]
28. Antiandrogen monotherapy: recommendations for the treatment of prostate cancer.
Sciarra A; Cardi A; Di Silverio F
Urol Int; 2004; 72(2):91-8. PubMed ID: 14963347
[TBL] [Abstract][Full Text] [Related]
29. Influence of different types of antiandrogens on luteinizing hormone-releasing hormone analogue-induced testosterone surge in patients with metastatic carcinoma of the prostate.
Schulze H; Senge T
J Urol; 1990 Oct; 144(4):934-41. PubMed ID: 2144596
[TBL] [Abstract][Full Text] [Related]
30. Treatment of advanced prostatic cancer.
Sogani PC; Fair WR
Urol Clin North Am; 1987 May; 14(2):353-71. PubMed ID: 2953100
[TBL] [Abstract][Full Text] [Related]
31. [Cancer of the prostate: new hormone therapies].
Namer M; Boublil JL; Kather R; Cavaglione G
Bull Cancer; 1986; 73(1):47-55. PubMed ID: 3779122
[TBL] [Abstract][Full Text] [Related]
32. [Effects of cyproterone acetate and flutamide on blood calcium and bone structure].
Manso Rodríguez G; Gutiérrez Cecchini B; Sala Blanco J; Hidalgo Balsera A
Arch Esp Urol; 1986 Oct; 39(8):534-8. PubMed ID: 2950829
[No Abstract] [Full Text] [Related]
33. New forms and future perspectives in endocrine treatment of prostatic carcinoma.
Jacobi GH; Wenderoth UK
Prog Clin Biol Res; 1984; 153():529-45. PubMed ID: 6236463
[No Abstract] [Full Text] [Related]
34. Prostate cancer treated by anti-androgens: is sexual function preserved? EORTC Genitourinary Group. European Organization for Research and Treatment of Cancer.
Schröder FH; Collette L; de Reijke TM; Whelan P
Br J Cancer; 2000 Jan; 82(2):283-90. PubMed ID: 10646878
[TBL] [Abstract][Full Text] [Related]
35. [Antiandrogens].
Reznikov AG; Varga SV
Probl Endokrinol (Mosk); 1979; 25(3):79-86. PubMed ID: 156919
[No Abstract] [Full Text] [Related]
36. Reduction of flutamide-induced alanine aminotransferase elevation after replacement by bicalutamide in a patient with N+ disease treated with maximal androgen blockade as a primary treatment.
Palmberg C; Kylmala T; Tammela T
Br J Urol; 1997 May; 79(5):808-9. PubMed ID: 9158528
[No Abstract] [Full Text] [Related]
37. Pharmacology of antiandrogens.
Neumann F; Töpert M
J Steroid Biochem; 1986 Nov; 25(5B):885-95. PubMed ID: 2949114
[TBL] [Abstract][Full Text] [Related]
38. Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice.
Plante M; Lapointe S; Labrie F
J Steroid Biochem; 1988 Jul; 31(1):61-4. PubMed ID: 2456423
[TBL] [Abstract][Full Text] [Related]
39. Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection.
Nguyen TV; Yao M; Pike CJ
Endocrinology; 2007 Jun; 148(6):2936-43. PubMed ID: 17347309
[TBL] [Abstract][Full Text] [Related]
40. Antiandrogens: clinical applications.
Sciarra F; Toscano V; Concolino G; Di Silverio F
J Steroid Biochem Mol Biol; 1990 Nov; 37(3):349-62. PubMed ID: 2147859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
